AnGes (STU:AJW) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AJW AnGes Inc STU:AJW
45 GF Score
Price €0.24
GF Value €0.52
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is AnGes Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:AJW vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, AnGes's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AnGes Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnGes's Short Interest distribution charts can be found below:

* The bar in red indicates where AnGes's Short Interest falls into.


STU:AJW
45GF Score
AnGes Inc STU:AJW
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AnGes (STU:AJW) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be undervalued. The current stock price of €0.24 is trading 53.8% below its estimated GF Value™ of €0.52. GuruFocus considers AnGes to be Possible Value Trap.

Key valuation signals for STU:AJW:

  • Short Interest:
  • GF Value™: €0.52 vs. price of €0.24 (53.8% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the STU:AJW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AnGes Business Description

Other Exchanges 4563:Japan
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
45GF Score

Get the complete analysis for STU:AJW

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.52
GF Value